Tourmaline Bio (TRML) Misses Q2 EPS by 90c
Tweet
Share
E-mailGet Alerts TRML Hot Sheet
Join SI Premium – FREE
Tourmaline Bio (NASDAQ: TRML) reported Q2 EPS of ($0.90).
For earnings history and earnings-related data on Tourmaline Bio (TRML) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi upgrades Bath & Body Works to Buy with $25 price target
- uCloudlink Group Inc. (UCL) Misses Q2 EPS by 1c ; Offers Guidance
- PENN Entertainment (PENN) Reiterated at Market Outperform by Citizens as Relocation Announced
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
